News
December 18, 2017: 
-BPL has signed an agreement with a global company (Fortune500) to collaborate in the development of a new protein-based drug candidate.
According to the agreement, BPL will develop a bacterial fermentation, refolding process,
purification and formulation as well as the related analytical testing methods.
For this project, BPL will  utilize its know-how and experience in recombinant protein expression in bacterial systems, purification and product formulation.
 

 November 2017
-BPL has signed an agreement with US based company for the development and production of series of enzymes and their immobilization to solid matrices. BPL will utilize its know-how and experience in recomninant enzyme expression in bacterial systems, purification and product formulation.



-BPL is relocating to a new facility in Yavne- 15 Nahal Snir st. The facility, designed and constructed specially according to BPL's plans and requirements, will be ready by ebd December 2017. BPL will start operation in the new facility by beginning January 2018.





 
 
Mailing List

Please enter your e-mail address

 Send

 
Share
Operating Principles
Meet/exceed expectations
Offer sustainable solutions for client needs
Partnership and building trust
Seamless and open communications with the technical staff
Provide a high level of process judgment and regulatory acumen
Integrate all development requirements to save time, cost and mitigate risk
Increase speed and flexibility to our clients
 
Testimonials:
 
"Highly experienced staff with a wealth of technical knowledge
and superior process development expertise"
CEO, CELL-BASED THERAPEUTICS COMPANY
 
“The team works day and night to deliver”
Pharmaceutical Sponsor, PROKARYOTIC EXPRESSION SYSTEM
BPL Biologics     19 Hidekel st. Yavne POB 13240  8122614  Israel
Tel: +972.76.548.8118   US: +973.723.9000